Novo’s (NVO) GLP-1 portfolio includes semaglutide, an injectable marketed as Wegovy for weight loss, and Ozempic for Type 2 ...
HealthDay on MSN34m
GLP-1 Drugs Improve Outlook For Kidney TransplantsKey Takeaways GLP-1 drugs might help a kidney transplant succeedPeople taking the drugs had a lower risk of organ failure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback